HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Global Network Improves Access to Diagnostic Insights

By HospiMedica International staff writers
Posted on 24 Oct 2018
Print article
Quest Diagnostics (Madison, NJ, USA), a leading provider of diagnostic information services, together with other diagnostic services providers, have announce the formation and launch of the Global Diagnostics Network (GDN), a strategic working group of diagnostic laboratories, each committed to unleashing and sharing local innovation to increase global access to diagnostic science, information, and services in order to improve the delivery of global healthcare.

GDN initiatives will benefit patients, healthcare providers, referring practitioners, pharmaceutical innovators, government agencies, non-governmental organizations (NGOs), and academic institutions. Starting priority areas of focus include a global launch platform for high quality companion diagnostics and the creation of an emerging pathogen preparedness network in order to expedite infectious disease research and response. Additional initiatives will be rolled out based on regional and global priorities.

“The Global Diagnostics Network will help solve some of the world's most pressing healthcare challenges by enabling fast and consistent access to leading diagnostic innovations and best practices,” said Steve Rusckowski, chairman, president, and CEO of Quest Diagnostics. “As we met with regional lab leaders over the past year, it became clear that we can accelerate the development and delivery of advanced diagnostics and diagnostic insights by bringing together our peers and sharing best practices.”

“The GDN collaboration will open up new opportunities by removing silos around unique knowledge and resources,” said Carrie Eglinton Manner, senior VP of advanced diagnostics at Quest Diagnostics. “We see this as a pragmatic approach to driving growth and excellence for all network members, while providing customers global access to innovations in diagnostics science, information, and service delivery.”

In addition to Quest Diagnostics, charter members of the GDN are Al Borg Medical Laboratories (Jeddah, Saudi Arabia), Dasa (Sao Paolo, Brazil), GC Labs (Yongin-Si, South Korea), KingMed Diagnostics (Hong Kong, China), Primary Health Care (Sydney, Australia), and SYNLAB (Munich, Germany).

Related Links:
Quest Diagnostics
Global Diagnostics Network

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Ultra Low Floor Level Bed
Solite Pro

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The Nami S miniaturized ultrasonic scalpel enables faster and safer RAS (Photo courtesy of Nami Surgical)

Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery

Robot-assisted surgery (RAS) has gained significant popularity in recent years and is now extensively used across various surgical fields such as urology, gynecology, and cardiology. These surgeries, performed... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more